SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-159367
Filing Date
2024-06-11
Accepted
2024-06-11 20:43:56
Documents
1
Group Members
BAIN CAPITAL LIFE SCIENCES FUND II, L.P.BCIP LIFE SCIENCES ASSOCIATES, LPBCLS II EQUITY OPPORTUNITIES, LPBCLS II INVESTCO, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d772435dsc13da.htm SC 13D/A 93618
  Complete submission text file 0001193125-24-159367.txt   95486
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Subject) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90280 | Film No.: 241037312
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
BCLS SB Investco, LP (Filed by) CIK: 0001728056 (see all company filings)

IRS No.: 820630705 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A